@article{ATM24206,
author = {Constantine E. Kosmas and Delia Silverio and Andreas Sourlas and Peter D. Montan and Eliscer Guzman and Mario J. Garcia},
title = {Anti-inflammatory therapy for cardiovascular disease},
journal = {Annals of Translational Medicine},
volume = {7},
number = {7},
year = {2019},
keywords = {},
abstract = {Chronic subclinical inflammation is a central process in the pathogenesis of cardiovascular disease (CVD) and it has been linked with both the initiation and progression of atherosclerosis. Several pro-inflammatory cytokines, such as the C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) have been described as independent risk factors for coronary heart disease and promoters of atherogenesis. Thus, extensive research is being conducted to assess the role of anti-inflammatory therapy in the primary and secondary prevention of CVD. Our review aims to provide the clinical and scientific data pertaining to the effects of different anti-inflammatory agents administered in patients with CVD.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24206}
}